$BCRX Recent News Hazmat-suit maker’s shares jump on

New Post Public Reply Private Reply Replies (0) Message Board

Dec 7, 2014 at 9:54 PM

$BCRX Recent News

Hazmat-suit maker’s shares jump on Ebola orders 11:49 a.m. Oct. 30, 2014 - Russ Britt
Ebola stocks mostly higher after virus confirmed in New York 1:59 p.m. Oct. 24, 2014 - Joseph Adinolfi
Fighting Ebola though investing: one firm’s approach 5:43 p.m. Oct. 21, 2014 - Wallace Witkowski
Is there an Ebola bubble in these stocks? 2:22 p.m. Oct. 16, 2014 - Wallace Witkowski
Ebola stocks: 2 to sell, and 5 to consider buying 11:09 a.m. Oct. 13, 2014 - The Trading Deck
U.S. to start screening for Ebola at five airports 5:25 p.m. Oct. 8, 2014 - Russ Britt
Ebola vaccine use likely to be confined, experts say 6:28 a.m. Oct. 8, 2014 - Russ Britt
Number of companies fighting Ebola grows, one wins fed OK 3:09 p.m. Oct. 6, 2014 - Russ Britt
Meet the drug companies fighting Ebola 3:14 p.m. Oct. 3, 2014 - Russ Britt
Getting Ebola treatments to market may take time 2:05 p.m. Oct. 1, 2014 - Russ Britt
Profiting from the fear as the market’s best quarter of the year begins 7:59 a.m. Oct. 1, 2014 - Shawn Langlois
Tekmira surges after Ebola report; ADP sinks 7:13 a.m. Oct. 1, 2014 - Ben Eisen
Stock markets start new quarter in good shape. 3:45 a.m. Oct. 1, 2014 - MarketWatch
Newscast: Wall Street notches winning quarter 5:31 p.m. Sept. 30, 2014 - MarketWatch
Use caution when investing in Ebola-related stocks 11:26 a.m. Aug. 28, 2014 - The Trading Deck
In focus: Bulls overconfident? 7:36 p.m. Aug. 13, 2014 - Lawrence G. McMillan
Ebola drug maker's shares soar as FDA opens door to treatment use 11:20 a.m. Aug. 8, 2014 - Russ Britt
6 stocks to watch 2:13 p.m. June 4, 2014 - The Trading Deck
S&P 500 reaches uncharted territory (that’s bullish) 12:00 p.m. March 5, 2014 - Michael Ashbaugh
U.S. stocks rise on ‘buy-the-dip’ mentality 3:31 p.m. April 8, 2013 - Kate Gibson

Biotech industry group supports adding Ebola to Voucher Program Act 1:57 p.m. Dec. 5, 2014 - Seeking Alpha
Brinson Patrick's Christopher S. James: All Catalysts Are Not Created Equal 8:55 a.m. Dec. 5, 2014 - Seeking Alpha
Hydration could save many Ebola victims 7:19 a.m. Dec. 5, 2014 - Seeking Alpha
UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals Following EU Physicians Survey 9:27 a.m. Dec. 4, 2014 - benzinga.com
5 Critical Biotech Drug Dates and Events for December 1:23 p.m. Dec. 1, 2014 - 247WallSt.com
2nd Half Of 2014 Biotechnology Catalysts: Part 5 9:59 a.m. Dec. 1, 2014 - Seeking Alpha
December's Essential, Stock-Moving Biotech Events Explained While Eating Turkey 6:00 a.m. Nov. 26, 2014 - TheStreet.com
5 Stocks to Watch Closely for the Rest of 2014 2:38 a.m. Nov. 26, 2014 - InvestorPlace.com
Aethlon Medical up on successful Ebola treatment 12:06 p.m. Nov. 17, 2014 - Seeking Alpha
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak 4:24 p.m. Nov. 13, 2014 - Seeking Alpha
These Ebola Stocks Have It All Riding on Africa Drug Trials 4:17 a.m. Nov. 13, 2014 - InvestorPlace.com
Ebola Stock Short Interest Surprise 1:44 p.m. Nov. 12, 2014 - 247WallSt.com
Why We Are Short Tekmira 10:48 a.m. Nov. 10, 2014 - Seeking Alpha
4 Stocks to Look at via Ebola Crisis - Analyst Blog 10:43 a.m. Nov. 10, 2014 - Zacks.com
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.2% - Tale of the Tape 8:44 a.m. Nov. 10, 2014 - Zacks.com
BioCryst Pharmaceuticals' (BCRX) CEO Jon Stonehouse on Q3 2014 Results - Earnings Call Transcript 11:45 p.m. Nov. 8, 2014 - Seeking Alpha
10-Q: BIOCRYST PHARMACEUTICALS INC 4:18 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
BioCryst Pharmaceuticals (BCRX) Q3 2014 Results - Earnings Call Webcast 10:55 a.m. Nov. 6, 2014 - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Nov. 5, 2014 - Seeking Alpha
CDC issues new guidelines over Ebola 4:10 a.m. Oct. 28, 2014 - Seeking Alpha

Bellicum Announces New Director, Executive Management Appointments 7:58 a.m. Dec. 5, 2014 - BusinessWire - BZX
BioCryst to Present at Two Upcoming Investor Conferences 7:10 a.m. Nov. 20, 2014 - GlobeNewswire
BioCryst Reports Third Quarter 2014 Financial Results 6:48 a.m. Nov. 6, 2014 - GlobeNewswire
BioCryst to Announce Third Quarter 2014 Financial Results November 6 5:56 a.m. Oct. 30, 2014 - GlobeNewswire
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014 5:59 a.m. Oct. 8, 2014 - GlobeNewswire
BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress 6:07 a.m. Oct. 7, 2014 - GlobeNewswire
Critical Alerts For Alibaba, BioCryst Pharmaceuticals, Trina Solar Limited, Vipshop Holdings and Visa Released By InvestorsObserver 8:31 a.m. Oct. 2, 2014 - PR Newswire - PRF
BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases 11:07 a.m. Sept. 18, 2014 - GlobeNewswire
BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting 10:00 a.m. Sept. 6, 2014 - GlobeNewswire
BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies 1:31 a.m. Sept. 4, 2014 - GlobeNewswire
BioCryst to Present at Rodman & Renshaw Conference 5:35 a.m. Sept. 3, 2014 - GlobeNewswire
BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting 5:52 a.m. Sept. 2, 2014 - GlobeNewswire
BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease 6:07 a.m. Aug. 29, 2014 - GlobeNewswire
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases 6:04 a.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 2:04 p.m. Aug. 12, 2014 - ACCESSWIRE
BioCryst Reports Second Quarter 2014 Financial Results 5:56 a.m. Aug. 5, 2014 - GlobeNewswire
BioCryst to Announce Second Quarter 2014 Financial Results August 5 6:06 a.m. July 22, 2014 - GlobeNewswire
Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum Pharma, Exact Sciences, and Vical Inc. 8:10 a.m. July 21, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firehawk Defense Secures $150M, Valuation Hits $1.4B

Firehawk Defense Lands Major Funding Think about it—Firehawk Defense, a gutsy Dallas-based new-kid-on-the-block, just snagged a whopping $150 million in fresh funding. The news? Their valuation's now sitting pretty at $1.4 billion. Not peanuts, by any means. For a company in the artillery game, that's a blast of an announcement. They're predicting they'll become the big...

Infrastructure Capital's ETFs: Dividend Windfall

Payout Boost for Income-Hungry Investors You know, it ain't every day you hear about dividend increases across the board. But Infrastructure Capital Advisors, that investment management powerhouse, is dishing out more dough to its investors through a dividend uptick. They're bumping up the payouts on not just one, but four of their ETFs: Bond Income ETF (BNDS), Equity...

RKD Groups' New Initiative: Monthly Giving Accelerator

Something’s cooking in the nonprofit realm, and it ain’t business as usual. RKD Group is stirring the pot big time with their latest endeavor: the Monthly Giving Accelerator. They’ve roped in Dana Snyder, who’s got a track record working with big guns like the Canadian Red Cross and Movember. Let’s just say she's got a Ph.D. in monthly donations. What’s the...

Shira Goodman Joins APEI Board: New Direction?

A New Chapter for American Public Education Alright, sit tight because this one’s got layers. American Public Education, Inc. (Nasdaq: APEI) just shook up its board by bringing in Shira Goodman, the former CEO of Staples. This move isn't just swapping one name for another; it’s about bolstering leadership at a time when strategic decisions are pivotal. Who is Shira...

Billd's Flex Line: Game-Changer for Subcontractor Credit

Billd's Bold Move Across America Forget piecemeal rollouts; Billd's taking their latest brainchild, Flex Line, right into the heart of America's subcontractor landscape. This isn't some flash-in-the-pan financial offering, either—it's a heavy-hitter poised to shake up the way subcontractors wrangle their working capital. We're talking about a line of credit that's as...

MetaOptics Bolsters Strategies with Buy-Back Mandate

Strategic Moves by MetaOptics If you thought the optics game was settled ages ago, think again. Today, MetaOptics Ltd (Catalist: 9MT), from sunny Singapore, is stirring up the pot with their latest game plan—a freshly minted Share Buy-Back Mandate. Shareholders at their general meeting were all thumbs up, and that's no surprise given what's on the table. Aim for...

Microplastics Found in Human Blood: Alarming Evidence

An Unsettling Discovery in Our Veins Microplastics in the blood? Yep, you read that right, and it’s not some sci-fi horror story—it’s today’s harsh reality. A riveting report from the likes of the Plastic Pollution Coalition and the Canadian Association of Physicians for the Environment has thrown a bucket of cold water on us. They uncovered microplastics in 96%...

Farizon SV 2027 Debuts in France Amid Market Shifts

A New Entry in the European Delivery Market The game's changing in European delivery, folks, and you better believe Geely Farizon's got a stake in it. Rolling out their all-electric Farizon SV Model Year 2027 at the world-renowned Marché International de Rungis, these folks are nothing if not ambitious. Nestled in the heart of the produce distribution world, Rungis...

D-Wave Faces Class Action: Investors Seek Justice

When you hear a heavyweight like D-Wave Quantum Inc. finding itself tangled in a securities fraud lawsuit, you know there’s something big brewing. D-Wave Quantum Inc. NASDAQ: QBTS is under the spotlight and the clock is ticking. If you've dipped your toes into their stock between February 26, 2026, and August 25, 2026, chances are, this might be your ticket to seek some...

Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...